|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 245.48 Million
|
|
Market Size (2030)
|
USD 330.59 Million
|
|
CAGR (2025-2030)
|
5.19%
|
|
Fastest Growing Segment
|
Companion Animal
|
|
Largest Market
|
North India
|
Market Overview
India Animal Vaccine Market was valued at USD 245.48 Million in 2024 and is anticipated to reach USD 330.59 Million by 2030, with a CAGR of 5.19% during 2025-2030.
This vital industry is centered on the research, production, and distribution of vaccines designed to protect animal health. These veterinary biologics are indispensable for safeguarding both livestock and companion animals, playing a crucial role in preventing infectious disease outbreaks and ensuring the well-being of India's diverse animal populations.
A primary catalyst for this market growth is the increasing public awareness of animal health and its connection to human safety. As consciousness about zoonotic diseases rises, the demand for preventive measures like vaccination intensifies. In response, governmental bodies are launching proactive initiatives to bolster animal healthcare infrastructure. These policies aim to improve the accessibility and distribution of essential vaccines, thereby strengthening disease control efforts for both commercial livestock and household pets, which in turn supports a healthier public environment for all.
Furthermore, continuous advancements in biotechnology are revolutionizing the development and efficacy of animal vaccines. Cutting-edge methods, including genetic engineering and recombinant DNA technology, are at the forefront of this innovation. These sophisticated techniques enable the creation of highly targeted vaccines that can elicit a powerful and specific immune response against pathogens. This scientific progress not only enhances the effectiveness and safety of modern vaccines but also streamlines the development of new solutions to combat emerging and persistent animal diseases effectively.
Key Market Drivers
Rising Livestock Disease Incidence
The increasing frequency of livestock diseases across India is a primary factor driving the demand for animal vaccines. As a cornerstone of the nation's agriculture sector, livestock farming supports the livelihoods of millions, with 8.8% of the Indian population employed in the sector and two-thirds of the rural community depending on it. The livestock sector contributes 4.35% to India's GDP. However, the high density and diversity of animal populations create ideal conditions for the rapid spread of infectious diseases.
To safeguard these valuable resources and maintain food security, there is a growing and urgent demand for effective vaccines against widespread threats. A meta-analysis of livestock diseases in India's North Eastern Region highlighted the significant prevalence of several diseases, including foot-and-mouth disease (FMD) at 21%, brucellosis in cattle at 17%, and classical swine fever at 31%. In 2025 alone, the Indian government confirmed 41 outbreaks of avian influenza across 10 states.
The economic consequences of livestock disease outbreaks are substantial, further fueling the need for preventive vaccination. A single outbreak can lead to severe financial losses for farmers due to reduced milk and meat production, decreased animal fertility, and high mortality rates.
- Foot-and-Mouth Disease (FMD) alone is estimated to cause annual economic losses of ₹20,000–₹25,000 crore in India due to factors like a 30-50% reduction in milk yield and trade restrictions.
- Brucellosis results in an estimated median loss of US$3.43 billion to the livestock population.
- Avian Influenza outbreaks have led to mass culling of poultry, with one incident in Andhra Pradesh resulting in the death of approximately 500,000 chickens and a 40% drop in chicken prices.
- Lumpy Skin Disease led to the death of over 1.8 million cows during a recent outbreak.
Growing Global Pet Adoption
The global trend of rising pet adoption is significantly impacting the demand for animal vaccines in India. As lifestyles evolve and more people embrace pet ownership, particularly of dogs and cats, there is a corresponding increase in demand for preventive healthcare. Modern pet owners are more aware and proactive, seeking comprehensive vaccination schedules to protect their companion animals from various preventable diseases. This shift reflects a deeper understanding of responsible pet care and the importance of ensuring the long-term health and well-being of animal family members.
Responsible pet ownership, a movement gaining momentum worldwide, strongly advocates for vaccination as a fundamental aspect of animal care. Animal shelters, rescue organizations, and veterinary clinics often mandate core vaccinations as part of adoption and wellness protocols. The COVID-19 pandemic amplified this trend by increasing pet adoption rates and heightening public awareness of zoonotic diseases. This has led to a more health-conscious pet-owning community in India, driving sustained growth in the companion animal vaccine market and aligning with global animal welfare standards.
Key Industry and Government Initiatives
Government agencies, animal associations, and leading industry players are playing a pivotal role in boosting the demand for animal vaccines in India. Government bodies, such as the Department of Animal Husbandry and Dairying, have launched ambitious nationwide initiatives to control and eradicate major livestock diseases. Programs like the National Animal Disease Control Program (NADCP) implement mass vaccination campaigns against FMD and brucellosis, creating a large-scale, consistent demand for these essential vaccines and strengthening the country's animal health infrastructure.
Alongside government efforts, animal advocacy groups and private sector leaders are crucial in driving vaccine adoption. Animal welfare associations conduct awareness campaigns to educate farmers and pet owners about the benefits of vaccination for disease prevention. In parallel, top animal healthcare companies invest heavily in research and development to produce innovative and effective vaccines. Through strategic distribution and collaboration with veterinary professionals, these companies ensure that high-quality vaccines are accessible, further stimulating market demand and promoting a culture of proactive animal healthcare.
Expansion of Animal Husbandry
The continuous expansion of animal husbandry in India is a significant driver for the animal vaccine market. As the country's population grows, so does the demand for animal-derived products like milk, meat, and eggs, prompting farmers to increase their livestock holdings. However, larger and more concentrated animal populations inherently carry a higher risk of rapid disease transmission. Consequently, vaccination has become an indispensable practice for protecting animal health, preventing large-scale outbreaks, and maintaining the productivity required to meet rising consumer needs.
Vaccination is increasingly recognized as a cost-effective strategy to protect the economic viability of animal husbandry. Outbreaks of diseases like FMD or avian influenza can lead to catastrophic financial losses for farmers and disrupt the food supply chain. By preventing illness and mortality, vaccines safeguard farmers' investments and ensure the sustainability of their operations. Government support through programs that promote animal husbandry and provide subsidized vaccination further reinforces this trend, solidifying the essential role of vaccines in India's growing agricultural landscape.
Download Free Sample Report
Key Market Challenges
High Vaccine Storage Costs
High storage costs represent a significant restraint on the Indian animal vaccine market. Maintaining vaccine efficacy is critically dependent on a consistent cold chain, but the required infrastructure is expensive. In many rural areas, unreliable electricity and frequent power outages threaten the stability of refrigeration. This makes it difficult to store vaccines at the required temperatures, risking spoilage and rendering them ineffective. The cost of backup power solutions like generators or solar-powered refrigerators is often prohibitively high for individual farmers and small veterinary clinics.
The financial burden of specialized storage facilities further suppresses vaccine demand. Establishing and maintaining cold rooms and dedicated vaccine refrigeration units requires a substantial initial investment and ongoing operational costs. For the millions of small-scale farmers who form the backbone of India's livestock sector, these expenses are often unattainable. This lack of accessible and affordable cold chain infrastructure directly limits the purchase and use of vaccines, creating a major barrier to widespread disease prevention efforts in the country's agricultural heartlands.
Shortage of Skilled Professionals
A critical shortage of qualified veterinarians and skilled farm workers is hampering the demand for animal vaccines in India. Effective vaccination programs depend on the expertise of trained professionals for proper administration, dosage, and scheduling. Without sufficient access to veterinary guidance, many farmers remain unaware of the importance of vaccinations or lack the knowledge to administer them correctly. This information gap leads to improper handling, reduced vaccine efficacy, and a general reluctance to invest in preventive healthcare for their livestock.
The scarcity of skilled farm labor also poses a significant challenge, particularly for implementing large-scale vaccination campaigns. Administering vaccines to large herds or flocks is a labor-intensive process that requires trained assistance. Furthermore, the cost associated with hiring veterinary services can be a major financial barrier for small and marginal farmers. This combination of limited professional access and affordability issues directly contributes to lower vaccination rates, hindering efforts to control animal diseases and protect agricultural productivity across India.
Key Market Trends
Government Initiatives
Proactive government initiatives are a major driver for the Indian animal vaccine market. Through comprehensive disease surveillance, mass vaccination programs, and public awareness campaigns, the government has been instrumental in safeguarding animal health. These concerted efforts, aimed at controlling and eradicating diseases like FMD, directly stimulate demand for vaccines. By prioritizing animal welfare and implementing preventative strategies, these programs create a stable environment for growth in the animal husbandry and veterinary sectors, bolstering the rural economy and ensuring a secure food supply chain.
The government's commitment extends to fostering research and innovation in animal healthcare. By investing in modern research facilities and promoting collaboration between academia, industry, and state agencies, India is cultivating an ecosystem for advanced veterinary science. This focus on technological adoption and skill development has improved the quality of animal care and positioned India as an emerging leader in the global veterinary market. These advancements attract investment, generate employment, and drive the socio-economic development of the nation's agricultural sector.
Technological Advancements
Recent technological advancements are revolutionizing the animal vaccine market by enabling the development of more efficient and targeted vaccines. Innovations utilizing artificial intelligence (AI) and big data analytics are accelerating the research and creation process, significantly improving vaccine efficacy. By analyzing vast datasets on pathogens and immune responses, scientists can design next-generation vaccines faster than ever before. This technological leap is ushering in a new era of proactive disease prevention, protecting animal populations from both existing and emerging health threats.
The impact of this accelerated vaccine development is profound, allowing for rapid responses to disease outbreaks and strengthening public health security. The ability to create and deploy highly effective vaccines quickly helps contain the spread of infectious diseases, including those with zoonotic potential. This paradigm shift empowers veterinary systems to manage health crises more effectively and protect the agricultural economy from the devastating impact of animal pandemics. As these technologies mature, they promise a future of enhanced global health and more resilient food systems.
Segmental Insights
Animal Type Insights
The poultry segment is projected to dominate the Indian animal vaccine market, driven by the nation's substantial and growing consumption of poultry products. As an essential source of protein for a large population, the health of poultry flocks is directly linked to food safety and public health. The rapid, exponential growth of the poultry industry to meet this rising demand amplifies the need for effective vaccination programs. Consequently, disease prevention in this sector is not merely an agricultural priority but a critical component of national food security.
This market leadership is also supported by a notable increase in health awareness among poultry farmers. Modern producers understand that proactive, preventive healthcare is essential for maintaining flock productivity and ensuring profitability. They are actively seeking reliable vaccines to protect their birds from costly diseases, viewing vaccination as a crucial investment in their business's sustainability. This combination of high consumption, industry growth, and farmer awareness creates a sustained and robust demand for advanced poultry vaccines across the Indian market.
Technology Insights
Based on technology, recombinant vaccines are set to lead the Indian market due to their superior design and efficacy. This advanced technology uses recombinant DNA to introduce one or more specific genes into an animal's cells, which stimulates a stronger and more targeted immune response. This precision allows for the creation of vaccines that are highly effective against particular pathogens. As a result of this well-defined and controlled development process, recombinant vaccines offer greater efficiency and an improved safety profile compared to traditional vaccines.
The growing preference for recombinant vaccines among veterinarians is a key factor in their projected market dominance. Professionals are increasingly opting for these solutions due to their reliability and reduced risk of side effects. This trend is amplified by the rising prevalence of complex animal diseases and a greater public understanding of animal health needs. As demand for high-quality veterinary care increases with pet ownership and livestock intensification, recombinant vaccines provide an innovative and effective tool to enhance animal welfare and disease control.
Download Free Sample Report
Regional Insights
The North region of India is poised to dominate the national animal vaccine market, a leadership position attributed to its significant concentration of livestock and poultry farms. States in this region have a deep-rooted history in agriculture, supporting a thriving industry where animal health is paramount. The high density of animal populations creates a substantial and consistent demand for vaccines to prevent and control disease outbreaks. This established agricultural infrastructure makes North India a critical hub for vaccine consumption and market growth.
A growing awareness among farmers and animal health professionals regarding the importance of vaccination further solidifies North India's market lead. Farmers increasingly view vaccines not as a cost but as a crucial investment for protecting animal health, boosting productivity, and ensuring farm profitability. This change is driven by educational initiatives and active promotion by veterinarians who emphasize the economic benefits of preventive healthcare, leading to higher adoption rates for vaccination protocols across the region.
The rising consumer demand for animal-derived food products like meat and milk also fuels the need for effective vaccines in North India. As the population's dietary preferences evolve, farmers must maintain healthy and productive livestock to meet this demand sustainably. Vaccination is essential for ensuring animals meet the stringent quality and safety standards required for food production. This market pull ensures a steady demand for vaccines, cementing the region's role in the future of India's animal health industry.
Recent Developments
- In September 2025, India's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have established the Veterinary Vaccine India Manufacturers Association (VVIMA). This association aims to foster collaboration with policymakers to address industry needs. The veterinary vaccine market in India is currently estimated at ₹2,000 crore (INR 20 billion).
- In February 2025, Biovet, a firm in the Bharat Biotech group, received approval from the Central Drugs Standard Control Organisation (CDSCO) for Biolumpivaxin. This is the world's first DIVA (Differentiating Infected from Vaccinated Animals) marker vaccine for Lumpy Skin Disease (LSD) in cattle and buffaloes. Developed in collaboration with the Indian Council of Agricultural Research (ICAR), the vaccine allows for the distinction between infected and vaccinated animals and has a planned production capacity of 500 million doses annually.
- In January 2025, A "Conclave on Pandemic Preparedness & Vaccine Innovation" was held in Hyderabad on January 10. The event was a collaboration between the Department of Animal Husbandry and Dairying, Indian Immunologicals Limited, and the National Dairy Development Board (NDDB). Key speakers emphasized the need for improved veterinary infrastructure, better diagnostic facilities, and the development of next-generation vaccines to prevent future pandemics and the spillover of zoonotic diseases. The government was also urged to increase spending on animal health and enhance supply chain and cold chain systems for vaccine delivery.
- In November 2024, Boehringer Ingelheim launched a next-generation poultry vaccine in India to target Marek's disease. Recommended for both in-ovo vaccination of eggs and for day-old chicks, the vaccine offers enhanced safety and efficacy against virulent strains of the disease.
Key Market Players
- Biovet Private Ltd.
- Hester Biosciences
Limited
- Intervet India
Private Limited(Merck Limited)
- Indovax Pvt. Ltd
- Bio-Med (P) Limited
- Zoetis India Ltd.
- Brilliant Bio Pharma
Private Limited
- Virbac Animal Health
India Pvt Ltd
- Elanco India Private
Limited
- Ceva Polychem Private Limited
|
By Animal Type
|
By Technology
|
By Disease
|
By Route of
Administration
|
By Distribution
Channel
|
By Region
|
- Livestock
- Swine
- Poultry
- Companion Animals
- Others
|
- Inactive Vaccine
- Live Attenuated
Vaccine
- Toxoid Vaccine
- Recombinant Vaccine
- Others
|
- Foot and Mouth
Disease
- New Castle Disease
- Infectious Bronchitis
- Infectious Bursal
Disease
- Fowl pox
- Rabies
- Others
|
- Subcutaneous
- Intramuscular
- Intraocular
- Oral
- Others
|
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies
|
|
Report
Scope:
In this
report, the India Animal Vaccine Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- India Animal Vaccine Market, By Animal Type:
o
Livestock
o
Swine
o
Poultry
o
Companion Animals
o
Others
- India Animal Vaccine Market, By Technology:
o
Inactive Vaccine
o
Live Attenuated
Vaccine
o
Toxoid Vaccine
o
Recombinant Vaccine
o
Others
- India Animal Vaccine Market, By Disease:
o
Foot and Mouth
Disease
o
New Castle Disease
o
Infectious Bronchitis
o
Infectious Bursal
Disease
o
Fowl pox
o
Rabies
o
Others
- India Animal Vaccine Market, By Route of
Administration:
o
Subcutaneous
o
Intramuscular
o
Intraocular
o
Oral
o
Others
- India Animal Vaccine Market, By Distribution
Channel:
o
Veterinary Hospitals
o
Veterinary Clinics
o
Pharmacies
- India Animal Vaccine
Market, By Region:
o
North
o
South
o
West
o
East
Competitive
Landscape
Company
Profiles: Detailed analysis of the major
companies present in the India Animal Vaccine Market.
Available
Customizations:
India Animal
Vaccine Market report with the given market data, TechSci Research
offers customizations according to a company's specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
India Animal
Vaccine Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]